Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03364114Not ApplicableTerminated

Endorotor Resection In Refractory Barrett's Dysplasia Patients

Role: lead

NCT04814693Not ApplicableEnrolling By Invitation

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

Role: collaborator

NCT04203667Not ApplicableCompleted

EndoRotor® Endoscopic Mucosal Resection System for the Colon

Role: lead

NCT03694210Not ApplicableCompleted

EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial

Role: lead

NCT03120195Not ApplicableCompleted

EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study

Role: collaborator

All 5 trials loaded